Alistair McCreadie

Chief Investment Officer, Asia Pacific at IP Group Plc

Alistair McCreadie

Alistair McCreadie

Chief Investment Officer, Asia Pacific at IP Group Plc

Biography

Alistair has over 20 years experience in investment banking and investment management. Most recently he ran a consulting firm covering IP commercialisation, early stage company development, government innovation policy and development and institutional investment in early-stage companies. Prior to this he was an adviser to, and managed investments in, a number of Australian university commercialisation funds. He has also been an advisor to superannuation funds and has managed venture portfolios for institutional investors. He started his career in banking and held senior executive positions in Australia and overseas with nab, ING Barings and ABN AMRO.

Overview
RelSci Relationships

245

Relationships
RelSci Relationships are individuals Alistair McCreadie likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Uniseed Management Pty Ltd.

Relationship likelihood: Strong

Investment Manager at Uniseed Ventures

Relationship likelihood: Strong

Company Secretary at Uniseed Management Pty Ltd.

Relationship likelihood: Strong

Investment Manager, Brisbane at Uniseed Management Pty Ltd.

Relationship likelihood: Strong

Investment Manager, Melbourne at Uniseed Management Pty Ltd.

Relationship likelihood: Strong

Senior Vice Principal at University of Melbourne

Relationship likelihood: Strong

Chief Financial Officer at The University of Queensland

Relationship likelihood: Strong

Former Chief Executive Officer & Director at Zenogen Pty Ltd.

Relationship likelihood: Strong

Chief Executive Officer & Director at Hatchtech Pty Ltd.

Relationship likelihood: Strong

Managing Director at Certa Therapeutics Pty. Ltd.

Relationship likelihood: Strong

Paths to Alistair McCreadie
Potential Connections via
Relationship Science
You
Alistair McCreadie
Chief Investment Officer, Asia Pacific at IP Group Plc
Career History
Chief Investment Officer, Asia Pacific
Current

IP Group Plc engages in commercializing intellectual properties mainly from its partner universities. It operates through the following segments: University Partnership Business, Venture Capital Fund Management, and In-Licensing Activity. The University Partnership Business segment includes the commercialization of intellectual property via the formation of long-term partner relationships with universities. The Venture Capital Fund Management segment deals with the management of venture funds focusing on early-stage UK technology companies. The In-Licensing Activity segment provides the in-licensing of drugable intellectual property from research intensive institutions. The company was founded by David Robert Norwood in 2001 and is headquartered in London, the United Kingdom.

Investment Manager
Current

Uniseed focuses on companies located in Australia. The firm mainly targets the sectors like bio-technology and other technology companies. they provides financing for seed & early stage capital requirements.

Management Team
Prior

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff of these organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund. A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011. With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position. On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million). Uniseed's partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network. The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Other Affiliations

Alistair McCreadie is affiliated with IP Group Plc, Uniseed Management Pty Ltd., Uniseed Ventures

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alistair McCreadie. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alistair McCreadie's profile does not indicate a business or promotional relationship of any kind between RelSci and Alistair McCreadie.